Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

SHA:600664 Revenue

Harbin Pharmaceutical Group had revenue of 3.95B CNY in the quarter ending June 30, 2025, a decrease of -1.24%. This brings the company's revenue in the last twelve months to 16.16B, up 1.65% year-over-year. In the year 2024, Harbin Pharmaceutical Group had annual revenue of 16.18B with 4.65% growth.

• Revenue (ttm): 16.16B
• Revenue Growth: +1.65%
• P/S Ratio: 0.57
• Revenue / Employee: 1.59M
• Employees: 10,180
• Market Cap: 9.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	16.18B	719.28M	4.65%
Dec 31, 2023	15.46B	1.65B	11.93%
Dec 31, 2022	13.81B	1.01B	7.86%
Dec 31, 2021	12.80B	2.01B	18.66%
Dec 31, 2020	10.79B	-1.04B	-8.76%